5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway
Authors:
Open Access
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 118, 109219
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81460283)
- National Natural Science Foundation of China (81660307)
- Natural Science Foundation of Inner Mongolia Autonomous Region (2016MS)
- Natural Science Foundation of Inner Mongolia Autonomous Region (2018 LH08078)
This publication has 38 references indexed in Scilit:
- Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagyNature Medicine, 2013
- Hypoxic preconditioning in an autohypoxic animal modelNeuroscience Bulletin, 2012
- Excessive Autophagy Contributes to Neuron Death in Cerebral IschemiaCNS Neuroscience & Therapeutics, 2012
- Sustained exposure to the DNA demethylating agent, 2′-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagyBiochemical Pharmacology, 2011
- Targeting DNA methylation for epigenetic therapyTrends in Pharmacological Sciences, 2010
- Activated Src kinases interact with the N‐methyl‐D‐aspartate receptor after neonatal brain ischemiaAnnals of Neurology, 2008
- Recycle or die: The role of autophagy in cardioprotectionJournal of Molecular and Cellular Cardiology, 2008
- Hypoxic Preconditioning Improves Spatial Cognitive Ability in MiceNeurosignals, 2006
- Phosphorylation and binding partner analysis of the TSC1–TSC2 complexBiochemical and Biophysical Research Communications, 2005
- Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signalingGenes & Development, 2003